ARTV
Price
$2.90
Change
+$0.08 (+2.84%)
Updated
Aug 26, 11:03 AM (EDT)
Capitalization
68.7M
84 days until earnings call
GBIO
Price
$6.13
Change
+$0.03 (+0.49%)
Updated
Aug 26, 11:24 AM (EDT)
Capitalization
41.09M
71 days until earnings call
Interact to see
Advertisement

ARTV vs GBIO

Header iconARTV vs GBIO Comparison
Open Charts ARTV vs GBIOBanner chart's image
Artiva Biotherapeutics
Price$2.90
Change+$0.08 (+2.84%)
Volume$100
Capitalization68.7M
Generation Bio
Price$6.13
Change+$0.03 (+0.49%)
Volume$200
Capitalization41.09M
ARTV vs GBIO Comparison Chart in %
Loading...
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTV vs. GBIO commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ARTV: $2.82 vs. GBIO: $6.10)
Brand notoriety: ARTV and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 10% vs. GBIO: 14%
Market capitalization -- ARTV: $68.7M vs. GBIO: $41.09M
ARTV [@Biotechnology] is valued at $68.7M. GBIO’s [@Biotechnology] market capitalization is $41.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ARTV is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 4 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 4 bullish, 4 bearish.
  • GBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARTV is a better buy in the short-term than GBIO.

Price Growth

ARTV (@Biotechnology) experienced а -9.03% price change this week, while GBIO (@Biotechnology) price change was -7.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +17.87%, and the average quarterly price growth was +32.49%.

Reported Earning Dates

ARTV is expected to report earnings on Nov 18, 2025.

GBIO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($68.7M) has a higher market cap than GBIO($41.1M). GBIO YTD gains are higher at: -42.453 vs. ARTV (-72.024). GBIO has higher annual earnings (EBITDA): -69.92M vs. ARTV (-79.07M). ARTV (142M) and GBIO (141M) have equal amount of cash in the bank . ARTV has less debt than GBIO: ARTV (13.2M) vs GBIO (85.3M). GBIO has higher revenues than ARTV: GBIO (21.2M) vs ARTV (0).
ARTVGBIOARTV / GBIO
Capitalization68.7M41.1M167%
EBITDA-79.07M-69.92M113%
Gain YTD-72.024-42.453170%
P/E RatioN/AN/A-
Revenue021.2M-
Total Cash142M141M101%
Total Debt13.2M85.3M15%
TECHNICAL ANALYSIS
Technical Analysis
ARTVGBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHKSF7.50N/A
N/A
Asahi Kaisei Corp.
RBTK2.00N/A
N/A
Zhen Ding Resources Inc.
BSHI14.00N/A
N/A
Boss Holdings, Inc.
HNLGY8.83N/A
N/A
Hang Lung Group Ltd.
TPPM0.06N/A
N/A
TMPOS Inc

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with TNFA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
-2.08%
TNFA - ARTV
47%
Loosely correlated
+9.60%
ERAS - ARTV
35%
Loosely correlated
-0.62%
GBIO - ARTV
34%
Loosely correlated
-5.43%
CELC - ARTV
34%
Loosely correlated
-6.05%
RLYB - ARTV
33%
Loosely correlated
-7.06%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-5.43%
CABA - GBIO
47%
Loosely correlated
-1.85%
MGNX - GBIO
46%
Loosely correlated
-2.96%
OVID - GBIO
44%
Loosely correlated
+10.68%
SYRE - GBIO
43%
Loosely correlated
-4.60%
IDYA - GBIO
42%
Loosely correlated
-1.63%
More